Showing results (621-630 of 890) with videos related to

Sort By:
Pageof 89
Gastroenterology|July 1, 1980
Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomachT Chiba, T Taminato, S Kadowaki, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|July 1, 1997
Sonographic detection of tumor blood flow using a new contrast agent in woodchuck hepatomasT Nada, F Moriyasu, Y Kono, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Pepsinogen C gene product is a possible growth factor during gastric mucosal healingK Kishi, Y Kinoshita, Y Matsushima, et al.
Ultrasound in Medicine & Biology|January 1, 1997
Gray scale second harmonic imaging of the liver: a preliminary animal studyY Kono, F Moriyasu, T Nada, et al.
Journal of Gastroenterology|May 30, 1998
Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: the MIB-1 labeling index is the most effective parameterY Saito, Y Matsuzaki, M Doi, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 1, 1996
Lingual carcinoma. Correlation of MR imaging with histopathological findingsA Arakawa, J Tsuruta, R Nishimura, et al.
Development (Cambridge, England)|June 1, 1997
The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factorH Ohuchi, T Nakagawa, A Yamamoto, et al.
Parasite Immunology|December 30, 2014
Impairment of host resistance to helminthes with age in murine small intestineM Morimoto, C Saito, C Muto, et al.
Mucosal Immunology|January 28, 2016
Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitisT Watanabe, Y Sadakane, N Yagama, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2015
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitisK Ashida, Y Sakurai, A Nishimura, et al.
Pageof 89